Cargando…
Glycation modulates glutamatergic signaling and exacerbates Parkinson’s disease-like phenotypes
Alpha-synuclein (aSyn) is a central player in the pathogenesis of synucleinopathies due to its accumulation in typical protein aggregates in the brain. However, it is still unclear how it contributes to neurodegeneration. Type-2 diabetes mellitus is a risk factor for Parkinson’s disease (PD). Intere...
Autores principales: | Chegão, Ana, Guarda, Mariana, Alexandre, Bruno M., Shvachiy, Liana, Temido-Ferreira, Mariana, Marques-Morgado, Inês, Fernandes Gomes, Bárbara, Matthiesen, Rune, Lopes, Luísa V., Florindo, Pedro R., Gomes, Ricardo A., Gomes-Alves, Patrícia, Coelho, Joana E., Outeiro, Tiago Fleming, Vicente Miranda, Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038780/ https://www.ncbi.nlm.nih.gov/pubmed/35468899 http://dx.doi.org/10.1038/s41531-022-00314-x |
Ejemplares similares
-
Glycation potentiates neurodegeneration in models of Huntington’s disease
por: Vicente Miranda, Hugo, et al.
Publicado: (2016) -
Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease
por: Vicente Miranda, Hugo, et al.
Publicado: (2017) -
Glycation in Huntington’s Disease: A Possible Modifier and Target for Intervention
por: Brás, Inês Caldeira, et al.
Publicado: (2019) -
Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson’s Disease
por: König, Annekatrin, et al.
Publicado: (2018) -
From Molecular to Functional Effects of Different Environmental Lead Exposure Paradigms
por: Shvachiy, Liana, et al.
Publicado: (2022)